- Report
- August 2025
- 185 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- September 2025
- 250 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- October 2025
- 192 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- October 2025
- 184 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- October 2025
- 199 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- August 2025
- 193 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- August 2025
- 198 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- August 2025
- 192 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- August 2025
- 189 Pages
Global
From €3181EUR$3,545USD£2,792GBP
€3535EUR$3,939USD£3,102GBP
- Report
- September 2025
- 250 Pages
Global
From €4029EUR$4,490USD£3,536GBP
- Report
- June 2025
- 200 Pages
Global
From €2503EUR$2,789USD£2,196GBP
- Report
- May 2024
- 134 Pages
Global
From €4957EUR$5,524USD£4,351GBP
€5832EUR$6,499USD£5,118GBP
- Report
- October 2025
- 83 Pages
Global
From €3500EUR$4,178USD£3,179GBP
- Report
- November 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,087GBP
- Report
- November 2025
- 50 Pages
Global
From €2378EUR$2,650USD£2,087GBP

Tenofovir is an antiretroviral drug used to treat HIV/AIDS. It is a nucleotide reverse transcriptase inhibitor (NRTI) that works by blocking the action of the reverse transcriptase enzyme, which is responsible for the replication of HIV. Tenofovir is used in combination with other antiretroviral drugs to treat HIV infection. It is also used to prevent HIV infection in people who are at high risk of infection. Tenofovir is available in both oral and injectable forms.
Tenofovir is a widely used antiretroviral drug for the treatment of HIV/AIDS. It is generally well tolerated and has few side effects. It is also effective in reducing the risk of HIV transmission. Tenofovir is available in generic form, which makes it more affordable for people living with HIV/AIDS.
Some companies in the Tenofovir market include Gilead Sciences, ViiV Healthcare, Mylan, and Cipla. Show Less Read more